BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Uracil Nucleotides

Below is an extended Uracil Nucleotides research listing. Click here to return to the Uracil Nucleotides main in depth entry.

Recent Publications on Uracil Nucleotides:

Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.
The phosphate, uracil, and ribose moieties of uracil nucleotides were...
Direct Link
17th July, 2008
Molecular Recognition Section, Laboratory of Bioorganic Chemistry, NIDDK,
Stereospecific synthesis of sugar-1-phosphates and their conversion to sugar nucleotides.
As Leloir glycosyltransferases are increasingly being used to prepare...
Direct Link
3rd June, 2008
Department of Chemistry, Dalhousie University, Halifax, Nova Scotia,
UDP is a competitive antagonist at the human P2Y14 receptor.
G protein-coupled P2Y receptors (P2Y-R) are activated by adenine and...
Direct Link
20th May, 2008
Department of Pharmacology, University of North Carolina, CB#7365 Mary
Uracil nucleotides: from metabolic intermediates to neuroprotection and neuroinflammation.
Uracil nucleotides (i.e., UTP and UDP) have been known for years as...
Direct Link
17th May, 2008
Laboratory of Molecular and Cellular Pharmacology of Purinergic
Opposite effects of uracil and adenine nucleotides on the survival of murine cardiomyocytes.
We previously showed that the human heart expresses all known P2X and P2Y...
Direct Link
19th April, 2008
Laboratory of Molecular and Cellular Pharmacology of Purinergic
Different patterns of Ca(2+) signals are induced by low compared to high concentrations of P2Y agonists in microglia.
Brain-resident macrophages (microglia) are key cellular elements in the...
Direct Link
12th April, 2008
Department of Cell Biology and Neuroscience, Section of Degenerative and
Structures of the human orotidine-5'-monophosphate decarboxylase support a covalent mechanism and provide a framework for drug design.
UMP synthase (UMPS) catalyzes the last two steps of de novo pyrimidine...
Direct Link
20th March, 2008
Department of Molecular Structural Biology, University of Gottingen,
Degradation of histone mRNA requires oligouridylation followed by decapping and simultaneous degradation of the mRNA both 5' to 3' and 3' to 5'.
Histone mRNAs are rapidly degraded at the end of S phase or when DNA...
Direct Link
14th March, 2008
Department of Biochemistry and Biophysics, University of North Carolina at
New ways to meet your (3') end oligouridylation as a step on the path to destruction.
Histone mRNAs are rapidly degraded at the end of S phase or when DNA...
Direct Link
14th March, 2008
Department of Microbiology, Immunology, and Pathology, Colorado State
A novel magnetic bead-based assay with high sensitivity and selectivity for analysis of telomerase in exfoliated cells from patients with bladder and colon cancer.
Telomerase activity is elevated in more than 85% of cancer cells and...
Direct Link
21st February, 2008
The Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch,
Roles for TbDSS-1 in RNA surveillance and decay of maturation by-products from the 12S rRNA locus.
The Trypanosoma brucei exoribonuclease, TbDSS-1, has been implicated in...
Direct Link
19th February, 2008
Department of Microbiology and Immunology, Witebsky Center for Microbial
Liver-specific increase of UTP and UDP-sugar concentrations in rats induced by dietary vitamin B6-deficiency and its relation to complex N-glycan structures of liver membrane-proteins.
This is the first known report on the influence of vitamin B6-deficiency...
Direct Link
26th January, 2008
Institut fur Biochemie und Molekularbiologie, Charite -
Ca2+-dependent ATP release from A549 cells involves synergistic autocrine stimulation by coreleased uridine nucleotides.
Extracellular ATP is a potent surfactant secretagogue but its origin in...
Direct Link
11th January, 2008
Centre hospitalier de l'Universite de Montreal - Hotel-Dieu, 3850
P2Y receptors: focus on structural, pharmacological and functional aspects in the brain. 3rd January, 2008
Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of
Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
OBJECTIVES: Suicide gene therapy with FCY1 gene, encoding cytosine...
Direct Link
8th November, 2007
Department of Medical and Surgical Sciences, University of Padova, Padova,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional